NR1I3 and fatty liver disease: In histologic examination, hepatic steatosis was slightly aggravated in CAR−/− mice (Figure 2(b)) compared with CAR+/+ mice (Figure 2(a)), but was nearly completely abolished after TCPOBOP treatment, which is a strong activator of CAR (Figure 2(c)).